Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Grilley-Olson, Juneko
ARGSARC, NCT05712694: Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects with Leiomyosarcoma	Recruiting	3	300	Canada, US, RoW	ADI PEG20, Pegargiminase, Placebo	Polaris Group	Soft Tissue Sarcoma	12/27	12/27
SUNRISELMS, NCT05269355 / 2022-000073-12: A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)	Active, not recruiting	2/3	360	Europe, Canada, US, RoW	Unesbulin, PTC596, Dacarbazine, DTIC, Placebo	PTC Therapeutics, PTC Therapeutics, Inc.	Leiomyosarcoma	06/24	06/24